BioDlink International Company Limited (HKG:1875)
Hong Kong · Delayed Price · Currency is HKD 4.150
-0.080 (-1.89%)
May 28, 2026, 11:44 AM HKT
HKG:1875 Market Cap
HKG:1875 has a market cap or net worth of 3.27 billion as of May 27, 2026. Its market cap has increased by 147.37% in one year.
Market Cap
3.27B
Enterprise Value
3.33B
Revenue
831.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.15
Market Cap Chart
Since November 8, 2019, HKG:1875's market cap has decreased from 3.57B to 3.27B, a decrease of -8.39%. That is a compound annual growth rate of -1.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 3.53B | 82.80% |
| Dec 24, 2025 | 1.93B | 39.66% |
| Dec 31, 2024 | 1.38B | -9.14% |
| Dec 29, 2023 | 1.52B | -17.92% |
| Dec 30, 2022 | 1.85B | -29.40% |
| Dec 31, 2021 | 2.63B | -0.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Luzhu Biotechnology | 3.88B |
| Shandong Boan Biotechnology | 3.77B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.49B |
| Clover Biopharmaceuticals | 3.32B |
| Jiangsu Recbio Technology | 3.18B |
| Medtide | 3.16B |
| TYK Medicines | 3.10B |